373528008: Neomycin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with antibacterial mechanism of action (substance)\Substance with aminoglycoside structure and antibacterial mechanism of action (substance)\Neomycin

\Drug or medicament (substance)\Anti-infective agent (substance)\Substance with antibacterial mechanism of action (substance)\Substance with aminoglycoside structure and antibacterial mechanism of action (substance)\Neomycin

\Substance categorised by structure\Chemical\Chemical categorized by structure\Organic compound\Glycoside\Aminoglycoside (substance)\Substance with aminoglycoside structure and antibacterial mechanism of action (substance)\Neomycin

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Neomycin	Is a	antibiotique cutané	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Neomycin	Is a	Substance with aminoglycoside structure and antibacterial mechanism of action (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Neomycin	Has disposition	Antibacterial (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Neomycin undecylenate	Is a	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Framycetin	Is a	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Neomycin measurement	Component	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Neomycin C	Is a	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Allergy to neomycin (finding)	Causative agent (attribute)	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Contact dermatitis caused by neomycin	Causative agent (attribute)	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Compound neomycin preparations	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing neomycin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Dexamethasone sodium phosphate + neomycin sulfate 1mg/3.5gm solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/5mg/1.6mg suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrocortisone+neomycin sulfate+polymyxin b sulphate 10mg/5ns/10000unt suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/7.5mg/10000unt suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/7.5mg/1000unt solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Neomycin sulphate	Is a	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Neomycin-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Neomycin palmitate	Is a	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Neomycin+hydrocortisone 0.5%/1.5% ear drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release solution for ear or eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Neomycin 0.5% cream BPC	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing hydrocortisone and neomycin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Topical neomycin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing framycetin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Framycetin sulfate [systemic]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Framycetin sulfate [eye]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Framycetin sulfate [ear]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Neomycin ear drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Neomycin ear ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Neomycin 0.5% ear drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrocortisone/neomycin cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Framycetin sulfate [skin]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release solution for ear or eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Clobetasol propionate+neomycin sulfate+Nystatin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Neomycin 0.5% ear drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Lidocaine- and neomycin- and polymyxin B-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing neomycin and polymyxin B and pramocaine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone+neomycin sulfate 0.1/0.5% ointment (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone+neomycin sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing clobetasone butyrate and neomycin sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Neomycin adverse reaction	Causative agent (attribute)	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Betamethasone- and neomycin-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Methylprednisolone- and neomycin-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing neomycin and triamcinolone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing neomycin and prednisolone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing fluocinolone and neomycin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing gramicidin and neomycin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing chlorhexidine and neomycin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing neomycin in otic dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing neomycin in ophthalmic dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Allergy to neomycin (finding)	Causative agent (attribute)	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing clobetasol and neomycin and nystatin in topical dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Neomycin sulphate	Is modification of (attribute)	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Neomycin palmitate	Is modification of (attribute)	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Allergy to framycetin (finding)	Causative agent (attribute)	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Neomycin undecylenate	Is modification of (attribute)	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing colistin and hydrocortisone and neomycin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug)	Has precise active ingredient	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug)	Has basis of strength substance (attribute)	False	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing neomycin and polymyxin B and prednisolone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing clobetasone and neomycin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Dexamethasone- and neomycin- and polymyxin B-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing bacitracin and neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing bacitracin and hydrocortisone and neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Dexamethasone- and neomycin-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing hydrocortisone and neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing clobetasol and neomycin and nystatin in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing neomycin in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Neomycin-containing product in ocular dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Neomycin- and triamcinolone-containing product in otic dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Betamethasone- and neomycin-containing product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Betamethasone- and neomycin-containing product in ocular dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing chlorhexidine and neomycin in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Hydrocortisone- and neomycin-containing product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing fluocinolone and neomycin in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing clobetasol and neomycin and nystatin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bacitracin and neomycin and polymyxin B only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only bacitracin and neomycin and polymyxin B and pramocaine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only clobetasol and neomycin and nystatin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Chlorhexidine and neomycin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Clobetasone and neomycin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only betamethasone and neomycin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only bacitracin and hydrocortisone and neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Colistin and hydrocortisone and neomycin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Dexamethasone and neomycin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Dexamethasone and neomycin and polymyxin B only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Neomycin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Methylprednisolone and neomycin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only neomycin and polymyxin B and pramocaine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Neomycin and polymyxin B and prednisolone only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing only neomycin and prednisolone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only neomycin and triamcinolone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin	Inferred relationship	Existential restriction modifier (core metadata concept)	2

Page 1 of 2 End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1198828019	Neomycin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1211996011	Neomycin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1198828019	Neomycin (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1198828019	Neomycin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1211996011	Neomycin	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1211996011	Neomycin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
54041000195119	neomicina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
69181000195117	Neomycin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
310021000077114	néomycine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
310021000077114	néomycine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
54041000195119	neomicina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
69181000195117	Neomycin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module